Related Experiment Video
Updated: Jun 11, 2025

07:23
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
175
Non-Coding RNAs and Innate Immune Responses in Cancer
Carlos Romero Díaz1, María Teresa Hernández-Huerta2, Laura Pérez-Campos Mayoral3
1Tecnológico Nacional de México/IT Oaxaca, Oaxaca 68030, Mexico.
Biomedicines
|September 28, 2024
Summary
Non-coding RNAs (ncRNAs) are key regulators of the innate immune system and cancer. Their shared properties with trained immunity offer new avenues for personalized cancer therapies targeting inflammation.
Area of Science:
- Immunology
- Molecular Biology
- Oncology
Background:
- Non-coding RNAs (ncRNAs) play crucial roles in gene regulation and innate immunity.
- Both ncRNAs and innate immunity are implicated in cancer development and progression.
- Understanding their interplay is vital for cancer research.
Purpose of the Study:
- To review major types of ncRNAs (siRNAs, miRNAs, piRNAs, lncRNAs).
- To focus on the roles of ncRNAs in cancer, innate immunity, and inflammation.
- To explore therapeutic potential arising from their interrelationships.
Main Methods:
- Literature review of ncRNAs, innate immunity, epigenetics, inflammation, and cancer.
- Analysis of shared properties between ncRNAs and trained immunity modulators.
- Synthesis of current knowledge on ncRNA functions in disease.
Main Results:
- ncRNAs are closely linked to innate immunity, epigenetics, chronic inflammation, and cancer.
- ncRNAs exhibit properties like inducibility, specificity, memory, and transfer, similar to trained immunity.
- Significant interrelationships exist between ncRNAs, innate immunity, and inflammation pathways.
Conclusions:
- The intricate relationship between ncRNAs and innate immunity is central to cancer biology.
- ncRNAs' roles in inflammation and trained immunity suggest novel therapeutic targets.
- Combining ncRNA modulation with inflammation control may lead to personalized cancer treatments.
Related Concept Videos
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
RNA Interference
26.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.0K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Cytotoxic T Cells-mediated Immune Response
857
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
857
Types of RNA
63.3K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
63.3K

